Brain-computer interfaces (BCIs) represent a groundbreaking intersection of medicine and technology, unlocking unprecedented capabilities in how humans interact with machines.This innovative field, spearheaded by pioneering neurotechnology companies like Neuralink, is not just revolutionizing assistive devices for those with disabilities; it is redefining the boundaries of human cognition.